PS

Patil Sachin Vasantrao

Active Director Director DIN 10976294
DIN 10976294 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Patil Sachin Vasantrao

Data last updated:

Patil Sachin Vasantrao is a Director at Amrutha Life Sciences Private Limited (since 2025). The company operates in Healthcare.

DIN 10976294
Primary Designation Director
Industry Healthcare
First Appointment 28 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20252025Active

Directorship timeline

Open interactive timeline →
Amrutha Life Sciences Private Limited
Premium access

Shareholding and investment profile for Patil Sachin Vasantrao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Patil Sachin Vasantrao

Patil Sachin Vasantrao currently holds 1 directorship: Amrutha Life Sciences Private Limited (Director, since 28 Feb 2025).

Patil Sachin Vasantrao was first appointed on 28 Feb 2025 as Director at Amrutha Life Sciences Private Limited.

The current boards of Patil Sachin Vasantrao's companies include Anil Shivasandra Prabhulingamurthy (Amrutha Life Sciences Private Limited), Dheeraj Damodar Shanbhag (Amrutha Life Sciences Private Limited), Humchadakatte Anantha Murthy Pramod Shankar (Amrutha Life Sciences Private Limited), Satish (Amrutha Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available